株式会社エテルナム announced that it will exhibit at the 9th Medical Japan Tokyo. The event will run from 7 to 9 October 2026 at Makuhari Messe, where the company plans to showcase its medical-institution-only skincare series “Eternam DR.”
株式会社エテルナム will exhibit at the 9th Medical Japan Tokyo (Medical, Nursing Care and Pharmacy Week Tokyo), to be held at Makuhari Messe from 7 October 2026 (Wednesday) to 9 October 2026 (Friday). The exhibition as a whole is expected to feature 650 exhibitors and attract 17,000 visitors, and the company aims to expand its contact with medical and healthcare professionals by showcasing its medical-institution-only skincare series “Eternam DR.”
Eternam DR is a medical-institution-only skincare series formulated with a high concentration of culture supernatant from human umbilical cord-derived mesenchymal stem cells. At its exhibition booth, the company will explain the products’ features and development background. Visitors will be offered a 20% discount on all products, a “1Day sample,” and, subject to certain conditions, a gift of a non-sale “culture supernatant essence mini bottle.”
The umbilical cord-derived raw material comes from umbilical cords and is produced using proprietary culture technology. The group company CET has established a process for securing a stable supply through its medical network. In 2024, 株式会社エテルナム established a joint research course with Juntendo University’s Graduate School Institute of Environmental Medicine and has presented research findings in the field of skin anti-aging regenerative medicine at academic conferences.
As safety testing for product commercialization, the company confirmed negative virus test results for healthy human donors and conducted various tests on the stem cells and culture supernatant. As a cosmetic ingredient, the material has passed 9 items at a level equivalent to that required for quasi-drugs. In addition, a total of 17 tests, including patch, allergy and anti-wrinkle tests, are being conducted in 2 stages.